ANTIFUSOGENIC ANTIVIRALS: DESIGN AND TESTING

Information

• Research Project
• 2064265

• ApplicationId

  2064265

• Core Project Number

  R44AI028126

• Full Project Number

  5R44AI028126-03

• Serial Number

  28126

• FOA Number

• Sub Project Id

• Project Start Date

  5/1/1989 - 35 years ago

• Project End Date

  7/31/1992 - 32 years ago

• Program Officer Name

• Budget Start Date

  8/1/1991 - 33 years ago

• Budget End Date

  7/31/1992 - 32 years ago

• Fiscal Year

  1991

• Support Year

  3

• Suffix

• Award Notice Date

  8/9/1991 - 33 years ago

Organizations

• SERES LABORATORIES, INC.

DESCRIPTION (adapted from applicant's abstract): This Phase-II proposal describes the synthesis of ten trial ligands to test their ability to prevent membrane fusion of influenza virus by binding to the hemagglutinin (HA) site of the envelope protein. Trial ligands that inhibit exposure of the fusion peptide of HA, and show in vitro inhibition of viral fusion, will be tested for antiviral activity by plaque assay.

IC Name

• Activity

  R44

• Administering IC

  AI

• Application Type

  5

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

• Sub Project Total Cost

• ARRA Funded

• CFDA Code

  856

• Ed Inst. Type

• Funding ICs

• Funding Mechanism

• Study Section

  PSF

• Study Section Name

  Physiological Sciences Study Section

• Organization Name

  SERES LABORATORIES, INC.

• Organization Department

• Organization DUNS

• Organization City

  SANTA ROSA

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  954032062

• Organization District

  UNITED STATES